The Enterprise Value as of March 2026 (TTM) for Oruka Therapeutics, Inc. (ORKA) is 1.46B

According to Oruka Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.46B. This represents a change of 86.91% compared to the average of 779.48M of the last 4 quarters.

Oruka Therapeutics, Inc. (ORKA) Historical Enterprise Value (quarterly & annually)

How has ORKA Enterprise Value performed in the past?

The mean historical Enterprise Value of Oruka Therapeutics, Inc. over the last ten years is 273.21M. The current 1.46B Enterprise Value has changed 53.23% with respect to the historical average. Over the past ten years (40 quarters), ORKA's Enterprise Value was at its highest in in the December 2025 quarter at 1.60B. The Enterprise Value was at its lowest in in the September 2024 quarter at -41902315.95.

Oruka Therapeutics, Inc. (ORKA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Oruka Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Oruka Therapeutics, Inc. (ORKA) Average Enterprise Value

How has ORKA Enterprise Value performed in the past?

The current Enterprise Value of Oruka Therapeutics, Inc. (ORKA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Oruka Therapeutics, Inc. (ORKA) Enterprise Value vs. Peers

How is ORKA’s Enterprise Value compared to its peers?

Oruka Therapeutics, Inc.’s Enterprise Value is greater than Phathom Pharmaceuticals, Inc. (702.89M), greater than BridgeBio Oncology Therapeutics Inc. (366.18M), greater than Rapport Therapeutics, Inc. Common Stock (1.00B), greater than Kodiak Sciences Inc. (1.26B), greater than Xencor, Inc. (1.03B), greater than Nurix Therapeutics, Inc. (1.13B), less than AnaptysBio, Inc. (1.95B), greater than UroGen Pharma Ltd. (938.88M), greater than Oculis Holding AG (1.09B), less than Mind Medicine (MindMed) Inc. (1.57B),

Build a custom stock screener for Oruka Therapeutics, Inc. (ORKA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oruka Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Oruka Therapeutics, Inc. (ORKA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Oruka Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.